Cargando…

Safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation

Detalles Bibliográficos
Autores principales: Mirea, L, Vasiliu, I Luca, Ungureanu, R, Balanescu, A, Grintescu, I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061754/
http://dx.doi.org/10.1186/cc9544
_version_ 1782200637468966912
author Mirea, L
Vasiliu, I Luca
Ungureanu, R
Balanescu, A
Grintescu, I
author_facet Mirea, L
Vasiliu, I Luca
Ungureanu, R
Balanescu, A
Grintescu, I
author_sort Mirea, L
collection PubMed
description
format Text
id pubmed-3061754
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30617542011-03-22 Safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation Mirea, L Vasiliu, I Luca Ungureanu, R Balanescu, A Grintescu, I Crit Care Poster Presentation BioMed Central 2011 2011-03-11 /pmc/articles/PMC3061754/ http://dx.doi.org/10.1186/cc9544 Text en Copyright ©2011 Mirea et al. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Mirea, L
Vasiliu, I Luca
Ungureanu, R
Balanescu, A
Grintescu, I
Safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation
title Safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation
title_full Safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation
title_fullStr Safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation
title_full_unstemmed Safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation
title_short Safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation
title_sort safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061754/
http://dx.doi.org/10.1186/cc9544
work_keys_str_mv AT mireal safetyofdrotrecoginalfaactivatedtreatmentinpatientswithseveresepsisonrenalreplacementtherapywithoutadditionalanticoagulation
AT vasiliuiluca safetyofdrotrecoginalfaactivatedtreatmentinpatientswithseveresepsisonrenalreplacementtherapywithoutadditionalanticoagulation
AT ungureanur safetyofdrotrecoginalfaactivatedtreatmentinpatientswithseveresepsisonrenalreplacementtherapywithoutadditionalanticoagulation
AT balanescua safetyofdrotrecoginalfaactivatedtreatmentinpatientswithseveresepsisonrenalreplacementtherapywithoutadditionalanticoagulation
AT grintescui safetyofdrotrecoginalfaactivatedtreatmentinpatientswithseveresepsisonrenalreplacementtherapywithoutadditionalanticoagulation